Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.

[1]  S. T. Traweek,et al.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. , 1993, The American journal of pathology.

[2]  W. McGuire,et al.  How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer , 1993, Cancer.

[3]  A. Campbell,et al.  Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients. , 1992, European journal of cancer.

[4]  D. Altman.  Categorising continuous variables. , 1991, British Journal of Cancer.

[5]  E. Lane,et al.  Basal cell-specific and hyperproliferation-related keratins in human breast cancer. , 1991, The American journal of pathology.

[6]  W. Lewis,et al.  Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer patients , 1990, Cancer.

[7]  F. Spyratos,et al.  Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. , 1990, Cytometry.

[8]  D. Visscher,et al.  Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[9]  D. Visscher,et al.  Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. , 1989, Analytical and quantitative cytology and histology.

[10]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.

[11]  L. Skoog,et al.  Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. , 1989, European journal of cancer & clinical oncology.

[12]  A. Gown,et al.  Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. , 1988, The American journal of pathology.

[13]  H. Clausen,et al.  Antikeratin antibodies in routine diagnostic pathology , 1988 .

[14]  O. Kallioniemi,et al.  Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. , 1987, European journal of cancer & clinical oncology.

[15]  L. Skoog,et al.  Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. , 1986, Breast cancer research and treatment.

[16]  L. Bobrow,et al.  Monoclonal antibody to cytokeratin for use in routine histopathology. , 1984, Journal of clinical pathology.

[17]  Robert C. Leif,et al.  Convention on nomenclature for DNA cytometry , 1984 .

[18]  K. Weber,et al.  Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[19]  I. Christensen,et al.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.

[20]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  D.,et al.  Regression Models and Life-Tables , 2022 .